Scientists around the world agree—the microbiome is a critical and emerging tool in drug development for many disease areas and therapeutic modalities. From neuroscience to oncology and even soil science, the microbiome holds great promise for better patient outcomes. This field has exploded in the last 10-years providing opportunities for interdisciplinary collaborations and new startups. What have we learned, where are we now and what does the next generation of microbiome research look like? Join us to hear from top industry experts and learn how the microbiome can accelerate your drug to market. Your gut instinct is right—you don’t want to miss this exploration into the new frontier of drug discovery.